Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence

Some 30–50% of the global population and almost 20% of the European population actually suffer from chronic pain, which presents a tremendous burden to society when this pain turns into a disability and hospitalization. Palmitoylethanolamide (PEA) has been demonstrated to improve pain in preclinical...

Full description

Bibliographic Details
Main Authors: Damiana Scuteri, Francesca Guida, Serena Boccella, Enza Palazzo, Sabatino Maione, Juan Francisco Rodríguez-Landa, Lucia Martínez-Mota, Paolo Tonin, Giacinto Bagetta, Maria Tiziana Corasaniti
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
palmitoylethanolamide
PEA
nociceptive pain
neuropathic pain
clinical setting
Online Access:https://www.mdpi.com/1999-4923/14/8/1672

Internet

https://www.mdpi.com/1999-4923/14/8/1672

Similar Items